Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qixiao Granules for Active Ulcerative Colitis
CTR20180327Phase 2Active
- Sponsor
- Hospital Affiliated to Changchun University of Traditional Chinese Medicine
- Start
- Apr 2018
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Qixiao Granules in autoimmune colitis, sponsored by Hospital Affiliated to Changchun University of Traditional Chinese Medicine. Started Apr 2018; status: active.
02
Drugs
Qixiao Granules
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on CTR20180327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180327.